Research Article
Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches
Table 2
Summary of the number and proportion of IDH-wildtype and IDH-mutant glioblastoma patients with SNVs in genes in the RTK/Ras/PI(3)K, p53 DNA damage repair, WNT signalling, SHH, NOTCH, Rb, and G-protein pathways.
|